Chemical Industry - REACH

Related services

• Toxicity and safety models
• Metabolites in safety testing (MIST)
• CYP identification, inhibition and induction
• Metabolite identification and stability
• Pre-clinical pharmacokinetics
• ONTOMINE - In silico bioactivity, adverse effect and toxicity screening for small molecules and metabolites
• ONTOMINE ADME - In silico models for logP, logD, logS, pKa

Toxicology for the 21st century

The growing unwillingness to accept risks and hazards in everyone’s daily life is putting a demand for the safety evaluation of substances, whether those are drugs, commodity chemicals, food additives or other molecules or mixtures. Toxicology and safety evaluations have a long history, dominated by various animal models as well as in vitro methods, associated with different international standards, like OECD assays and GLP requirements. While this battery of methods is considered to be the “golden standard” for safety evaluation and acknowledged by the regulatory authorities, there is a clear demand to compensate these tests with alterative in vivo models as well as in vitro, in silico and ‘omics developments – in general referred as Toxicology for the 21st century.

REACH and other regulations in safety assessment

Currently in Europe, the need for these compensatory method is arising due the REACH legislation in addition to the trend of more strict safety evaluations for the growing number of novel drugs and food additives being developed. Examples of these methods include various insect and fish models, biochemical and cell based assays as well as in silico toxicology with QSAR, PBPK and virtual organ models, predictive expert systems, toxicogenomics and various aspects of systems biology. While these alternative models are gaining support by some authorities, like US EPA, NTP and NCGC, their role currently is towards early-safety warning systems and prioritizing testing in the ”golden standard” models.

SBW in silico, in vitro and in vivo platform for toxicology and safety

SBW's research service platform covers many areas in toxicology and safety related assessments, including aspects of in silico, in vitro and in vivo methods. We offer multiple standardized in vitro and in vivo models for toxicology and safety, both under non-GLP as well as GLP standards.

In addition to these standardized assays, which under OECD GLP are required for regulatory preclinical and REACH testing, we also have extensive knowledge in in silico predictive toxicology and adverse effect models, including toxicogenomics, (Q)SAR models and well as OntoMine (US patented) expert system. OntoMine contains a knowledgebase, collected from literature and databases, hand curated and constantly expanded, containing around 3.000 endpoints of biological activity, mechanism/targets, adverse effects and various toxicities. The fingerprints of molecules in these endpoints allows fast prediction for toxicities, adverse effects, biological activities etc., for flagging toxic effects, HTS library selection, identification of promiscuous hits, lead chemistry scaffold hopping, drug repositioning and drug target identification.

In addition to Ontomine, we have expertise in other toxicology and safety prediction related software on the market. Further, we provide customized solutions for chemical inventory databases, analytics workflow development and tailored programming, data mining, statistics and database solutions for chemical industry.

With the various mentioned activities toxicology and safety assessments, SBW offers you a platform and experts for drug discovery, chemical safety and functional food research.

All our services are tailored per customer needs. For more information, contact us from this link.